17-10-1-1　ⓔ文献

  1. Dale DC: Neutropenia and neutrophilia. Williams Hematology, seventh edition (Lichtman MA, Kipps TJ, et al eds), McGraw–Hill, Medical Publication Division, 2006; 907–916.

  2. Nitta E, Izutsu K, et al: A high incidence of late–onset neutropenia following rituximab–containing chemotherapy as a primary treatment of CD20–positive B–cell lymphoma: a single–institution study. Annals Oncol, 2007; 18: 364–369.

  3. 小林正夫，川口浩史：自己免疫性好中球減少症．日本内科学会雑誌，2014; 103: 1639–1644.

  4. Wang H, Chuhjo T, et al: Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria–type cells in bone marrow failure syndrome. Blood, 2002; 100: 3897–3902.

  5. Bux J: Human neutrophil alloantigens. Vox Sang, 2008; 94: 277–285.

  6. Reil A, Sachs UJ, et al: HNA–1d: a new human neutrophil antigen located on Fcg receptor Ⅲb associated with neonatal neutropenia. Transfusion, 2013; 53: 2145–2151.

  7. Logue GI, Shastri KA, et al: Idiopathic neutropenia: antineutrophil antibodies and clinical correlations. Am J Med, 1991; 90: 211–216.

  8. Youinou P, Jamin C, et al: Diagnostic criteria for autoimmune neutropenia. Autoimmune Rev, 2014; 13: 574–576.

  9. Ditzel HJ, Masaki Y, et al: Cloning and expression of a novel human antibody–antigen pair associated with Felty’s syndrome. PNAS, 2000; 97: 9234–9239.

  10. Ohnston A, Uetrecht J: Current understanding of the mechanisms of idiosyncratic drug–induced agranulocytosis. Expert Opin Drug Metab Toxicol, 2015; 11: 243–257.

  11. Nooka AK: Drug–induced immune neutropenia/agranulocytosis. Oncology (Williston Park), 2013; 27 (Suppl 3): 11–18.

  12. Andersohn F, Konzen C, et al: Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med, 2007; 146: 657–665.

  13. Clark OA, Lyman GH, et al: Colony–stimulating factors for chemotherapy-induced febrile neutropenia: a meta–analysis of randomized controlled trials. J Clin Oncol, 2005; 23: 4198–4214.

  14. Horwitz M, Benson KF, et al: Mutations in ELA2, encoding neutrophil elastase, define a 21–day biological clock in cyclic haematopoiesis. Nat Genet, 1999; 23: 433–436.

  15. Bellanne–Chantelot C, Clauin S, et al: Mutations in the ELA2 gene correlate with more severe expression of neutropenia. A study of 81 patients from the French Neutropenia Register. Blood, 2004; 103: 4119–4125.

  16. D’Andrea AD: Cytokine receptors in congental hematopoietic disease. N Engl J Med, 1994; 330: 839–846.

  17. Roux A, Gonzalez F, et al: Update on pulmonary Pneumocystis jirovecii infection in non–HIV patients. Med Mal Infect, 2014; 44: 185–198.